{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:00:25Z","timestamp":1780614025430,"version":"3.54.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The development of metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with cardiovascular health (CVH) status and chronic inflammation. Life\u2019s Crucial 9 (LC9) is the most recent index to assess CVH; its association with MASLD and liver fibrosis is unclear. This study aimed to investigate the association of LC9 with MASLD and hepatic fibrosis and to reveal for the first time the mediating role of a novel inflammatory marker, neutrophil percentage-to-albumin ratio (NPAR), in the association between LC9 and MASLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was a cross-sectional analysis of data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018. The United States Fatty Liver Index (US-FLI)\u202f\u2265\u202f30 was used to diagnose MASLD, and liver stiffness measurement (LSM)\u202f&amp;gt;\u202f8.2 is defined as liver fibrosis. Weighted multifactorial regression, restricted cubic spline analysis (RCS), and subgroup analyses were used to assess the association between LC9 and MASLD and liver fibrosis. Mediation analysis was used to explore the possible mediating role of NPAR in the association of LC9 with MASLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 9,623 participants were included in this study. After adjusting for all confounders, LC9 was significantly and negatively associated with both MASLD (OR\u202f=\u202f0.59, 95% CI: 0.54\u20130.64) and hepatic fibrosis (OR\u202f=\u202f0.66, 95% CI: 0.45\u20130.97), with each 10-point increase in the LC9 score decreasing the prevalence by 41% and 34%, respectively. In subgroup analyses, interaction tests showed that age, education, deprivation, obesity, smoking, hypertension, diabetes, and hyperlipidemia significantly affected the association between LC9 and MASLD (P for interaction &amp;lt; 0.05). In addition, NPAR was positively associated with the prevalence of MASLD, with a 5% increase in the prevalence of MASLD for each unit increase in NPAR (OR\u202f=\u202f1.05, 95% CI: 1.01\u20131.09). The positive association between NPAR and MASLD was stronger in younger age groups (&amp;lt;60\u202fyears), non-drinkers, and participants without diabetes or hyperlipidemia. Mediation analysis showed that NPAR mediated 2.84% of the association between LC9 and MASLD (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Good CVH status (high LC9 score) was associated with lower prevalence of MASLD and liver fibrosis, and NPAR partially mediated the association between LC9 and MASLD. This study provides new epidemiological evidence for preventing MASLD by improving CVH and inflammatory modulation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1549089","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:10:34Z","timestamp":1749183034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between Life\u2019s Crucial 9 and metabolic dysfunction-associated steatotic liver disease: the mediating role of neutrophil-percentage-to-albumin ratio"],"prefix":"10.3389","volume":"12","author":[{"given":"Na","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life\u2019s essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1161\/CIR.0000000000000947","article-title":"Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association","volume":"143","author":"Levine","year":"2021","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.123.066132","article-title":"Strengthening the pillars of cardiovascular health: psychological health is a crucial component","volume":"149","author":"Gaffey","year":"2024","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13690-024-01331-3","article-title":"Association between life\u2019s essential eight and metabolic dysfunction-associated steatotic liver disease among US adults","volume":"82","author":"Wang","year":"2024","journal-title":"Arch Public Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"17188","DOI":"10.1038\/s41598-024-67728-w","article-title":"Association of Life\u2019s essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003\u20132018","volume":"14","author":"Liu","year":"2024","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12967-022-03839-0","article-title":"Associations between life\u2019s essential eight and non-alcoholic fatty liver disease among US adults","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1403720","DOI":"10.3389\/fnut.2024.1403720","article-title":"Associations of life's essential 8 with MAFLD and liver fibrosis among US adults: a nationwide cross-section study","volume":"11","author":"Liang","year":"2024","journal-title":"Front Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/nu15081892","article-title":"Predictive role of neutrophil-percentage-to-albumin ratio (NPAR) in nonalcoholic fatty liver disease and advanced liver fibrosis in nondiabetic US adults: evidence from NHANES 2017\u20132018","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"30403","DOI":"10.1038\/s41598-024-80801-8","article-title":"Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD","volume":"14","author":"Dong","year":"2024","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"21880","DOI":"10.1038\/s41598-024-71488-y","article-title":"The association between neutrophil percentage-to-albumin ratio (NPAR) and depression among US adults: a cross-sectional study","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.2105\/AJPH.2023.307490","article-title":"Data related to social determinants of health captured in the National Health and nutrition examination survey","volume":"113","author":"Lau","year":"2023","journal-title":"Am J Public Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.3390\/nu15234931","article-title":"Trends in oxidative balance score and prevalence of metabolic dysfunction-associated Steatotic liver disease in the United States: National Health and nutrition examination survey 2001 to 2018","volume":"15","author":"Tan","year":"2023","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"24627","DOI":"10.1038\/s41598-024-75274-8","article-title":"Association between magnesium depletion score and the risk of metabolic dysfunction associated steatotic liver disease: a cross sectional study","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive scores and serum biomarkers for fatty liver in the era of metabolic dysfunction-associated Steatotic liver disease (MASLD): a comprehensive review from NAFLD to MAFLD and MASLD","volume":"13","author":"Abdelhameed","year":"2024","journal-title":"Curr Obes Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12876-025-03870-7","article-title":"Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis","volume":"25","author":"Zhou","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jand.2018.05.021","article-title":"Update of the healthy eating index: HEI-2015","volume":"118","author":"Krebs-Smith","year":"2018","journal-title":"J Acad Nutr Diet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e2337011","DOI":"10.1001\/jamanetworkopen.2023.37011","article-title":"Depressive symptoms and mortality among US adults","volume":"6","author":"Zhang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12986-024-00821-z","article-title":"Cumulative exposure to AHA Life\u2019s essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study","volume":"21","author":"Yaqin","year":"2024","journal-title":"Nutr Metab (Lond)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"155643","DOI":"10.1016\/j.metabol.2023.155643","article-title":"A healthy lifestyle, Life\u2019s essential 8 scores and new-onset severe NAFLD: a prospective analysis in UK biobank","volume":"146","author":"He","year":"2023","journal-title":"Metabolism"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart","year":"2020","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"16831","DOI":"10.3748\/wjg.v20.i45.16831","article-title":"Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet","volume":"20","author":"Abenavoli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.3390\/nu15204468","article-title":"Effects of an eight week very low-calorie ketogenic diet (VLCKD) on white blood cell and platelet counts in relation to metabolic dysfunction-associated Steatotic liver disease (MASLD) in subjects with overweight and obesity","volume":"15","author":"De Nucci","year":"2023","journal-title":"Nutrients"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1426551","DOI":"10.3389\/fnut.2024.1426551","article-title":"Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility","volume":"11","author":"Mambrini","year":"2024","journal-title":"Front Nutr"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","article-title":"Cigarette smoking and liver diseases","volume":"77","author":"Marti-Aguado","year":"2022","journal-title":"J Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.2337\/dc11-1093","article-title":"Sleep architecture and glucose and insulin homeostasis in obese adolescents","volume":"34","author":"Koren","year":"2011","journal-title":"Diabetes Care"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic Steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1384003","DOI":"10.3389\/fpsyt.2024.1384003","article-title":"Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study","volume":"15","author":"Liang","year":"2024","journal-title":"Front Psych"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/HEP.0000000000000635","article-title":"Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes","volume":"79","author":"Ajmera","year":"2024","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e002243","DOI":"10.1136\/bmjdrc-2021-002243","article-title":"Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes","volume":"9","author":"Ajmera","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"106077","DOI":"10.1016\/j.psyneuen.2023.106077","article-title":"Longitudinal links between early adolescent temperament and inflammation among young black adults","volume":"152","author":"Brody","year":"2023","journal-title":"Psychoneuroendocrinology"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1549089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:10:35Z","timestamp":1749183035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1549089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":41,"alternative-id":["10.3389\/fnut.2025.1549089"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1549089","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1549089"}}